LCGC
RDY icon

Legacy Capital Group California’s Dr. Reddy's Laboratories RDY Stock Holding History

Legacy Capital Group California’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-13,741
Closed -$217K – 351
2024
Q4 		$217K Buy
13,741
+111
+0.8% +$1.67K 0.07% 306
2024
Q3 		$217K Buy
13,630
+270
+2% +$4.34K 0.07% 293
2024
Q2 		$204K Buy
+13,360
New +$191K 0.07% 292

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $70.2B AUM 29.99% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $345M AUM 10.59% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Legacy Capital Group California's RDY Position: Q1 2025 in Review

Legacy Capital Group California sold out of Dr. Reddy's Laboratories (RDY) in Q1 2025, closing a stake of 13,741 shares — an estimated $217K sold.

Legacy Capital Group California first reported a position in RDY in Q2 2024 and held it in 3 quarters. The position peaked at $217K in Q4 2024. 243 funds tracked by Wall St. Rank hold RDY as of Q1 2025.

  • Legacy Capital Group California reported no remaining Dr. Reddy's Laboratories position as of Q1 2025 after selling out during the quarter.
  • Legacy Capital Group California sold 13,741 Dr. Reddy's Laboratories shares in Q1 2025, an estimated $217K.
  • Legacy Capital Group California first reported a position in Dr. Reddy's Laboratories in Q2 2024 and held it in 3 quarters.
  • Legacy Capital Group California's Dr. Reddy's Laboratories position peaked at $217K in Q4 2024.
  • 243 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2025.

Based on Legacy Capital Group California's 13F filing for Q1 2025, filed 9 May 2025.